Improving alcohol treatment engagement for patients with liver disease
Adaptive Interventions to Improve Alcohol Treatment Engagement among Alcohol-related Liver Disease Patients
This study is looking to help people with alcohol-related liver disease get more involved in their treatment by using a mobile app and personalized support, making it easier for them to stay on track and improve their health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10875382 on NIH RePORTER |
What this research studies
This research aims to enhance the engagement of patients with alcohol-related liver disease (ALD) in treatment programs. It employs an adaptive intervention strategy that tailors support based on individual patient responses, using a mobile app and additional resources to encourage participation in alcohol treatment. The study will involve patients from hepatology clinics who have been diagnosed with ALD and have not engaged in treatment recently. By identifying those who may need extra help, the research seeks to improve both alcohol consumption and liver health outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who have been diagnosed with alcohol-related liver disease and have not engaged in treatment in the past month.
Not a fit: Patients who are not diagnosed with alcohol-related liver disease or who have recently engaged in alcohol treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase the number of ALD patients receiving effective treatment, leading to better health outcomes and reduced mortality.
How similar studies have performed: Previous research has shown that adaptive interventions can effectively improve treatment engagement in various health conditions, suggesting potential success for this approach in ALD.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Mellinger, Jessica Leigh — University of Michigan at Ann Arbor
- Study coordinator: Mellinger, Jessica Leigh
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.